Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone
Part of paid clinical trials in Scottsdale, Arizona.
- Sponsor
- Mayo Clinic
- Study ID
- NCT05033288
- Status
- Recruiting
Conditions
- Bone Sarcoma
- Chondrosarcoma
- Chordoma
- Ewing Sarcoma of Bone
- Pelvic Rhabdomyosarcoma
Eligibility Criteria
- Sex
- ALL
- Age
- 15 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Electronic Health Record Review — OTHERMedical records are reviewed
- Quality-of-Life Assessment — OTHERComplete quality of life questionnaires
Study Details
This study compares carbon ion therapy, surgery, and proton therapy to determine if one has better disease control and fewer side effects. There are three types of radiation treatment used for pelvic bone sarcomas: surgery with or without photon/proton therapy, proton therapy alone, and carbon ion therapy alone. The purpose of this study is to compare quality of life among patients treated for pelvic bone sarcomas across the world, and to determine if carbon ion therapy improves quality of life compared to surgery and disease control compared with proton therapy.
Key Dates
- Start date
- Jan 20, 2022
- Status verified
- Mar 2026
- Primary completion
- Aug 30, 2027
- Completion
- Aug 30, 2031
Study Design
- Enrollment
- 72 participants (estimated)
Arms
- Arm: Observational (questionnaires, medical record review)Patients complete quality of life questionnaires over 20 minutes at baseline (before any therapy), 2-4 and 5-9 months after completion of therapy, and then annually for up to 5 years. Patients' medical records are also reviewed.
Primary Outcome Measure
Average difference in change of functional quality of life (QOL) [ Time Frame: Baseline (pre-treatment) to 1 year after completion of treatment ]
Central Contacts
- Clinical Trials Referral Office855-776-0015
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Arizona | Scottsdale | Arizona | 85259 | Jonathan B. Ashman, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| Mayo Clinic in Florida | Jacksonville | Florida | 32224-9980 | Bradford S. Hoppe, MD (PRINCIPAL_INVESTIGATOR) |
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | Meng Welliver, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Scottsdale, AZ
Related Studies
- LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic OncologyPHASE4 · Enrolling By Invitation · Massachusetts General Hospital · Los Angeles, California
- Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway AlterationPHASE2 · Recruiting · Medical College of Wisconsin · Jacksonville, Florida
- Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With SarcomaRecruiting · Mayo Clinic · Rochester, Minnesota
- Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid TumorsPHASE1/PHASE2 · Recruiting · University of Florida · Gainesville, Florida